Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Lormetazepam
Drug ID BADD_D01321
Description Lormatazepam is an orally available benzodiazepine used in the UK for the treatment of short-term insomnia [L927]. It is marketed by Auden Mckenzie (Pharma Division) in 0.5 and 1 mg tablet formulations.
Indications and Usage For the treatment of short-term insomnia [L927]
Marketing Status approved
ATC Code N05CD06
DrugBank ID DB13872
KEGG ID D01657
MeSH ID C023842
PubChem ID 13314
TTD Drug ID D0I8HJ
NDC Product Code 12828-0021
UNII GU56C842ZA
Synonyms lormetazepam | methyllorazepam
Chemical Information
Molecular Formula C16H12Cl2N2O2
CAS Registry Number 848-75-9
SMILES CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain upper07.01.05.003--
Acute psychosis19.03.01.001--Not Available
Aggression19.05.01.001--Not Available
Agitation17.02.05.012; 19.06.02.001--
Altered state of consciousness19.07.01.003; 17.02.04.001--Not Available
Amnesia19.20.01.001; 17.03.02.001--
Anger19.04.02.001--Not Available
Angioedema23.04.01.001; 10.01.05.009; 22.04.02.008--Not Available
Anterograde amnesia19.20.01.005; 17.03.02.005--Not Available
Anxiety19.06.02.002--
Asthenia08.01.01.001--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Completed suicide19.12.01.001; 08.04.01.010--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Delusion19.10.01.001--
Dependence19.07.06.008--Not Available
Depressed level of consciousness17.02.04.002--
Depression19.15.01.001--
Derealisation19.10.05.004--Not Available
Dermatitis23.03.04.002--Not Available
Diplopia17.17.01.005; 06.02.06.002--Not Available
Disturbance in attention19.21.02.002; 17.03.03.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Drug dependence19.07.06.011--Not Available
Drug withdrawal syndrome19.07.06.013; 08.06.02.004--Not Available
Dry mouth07.06.01.002--
Dysgeusia07.14.03.001; 17.02.07.003--
Emotional disorder19.04.02.005--Not Available
Epilepsy17.12.03.002--Not Available
The 1th Page    1 2 3    Next   Last    Total 3 Pages